NCT07165353

Brief Summary

About 70% of people with a spinal cord injury in Switzerland have chronic pain that lasts more than 3 to 6 months. This pain can be caused by muscle or joint problems, or by nerve damage (neuropathic pain). Neuropathic pain is often hard to treat, and current treatments may cause side effects or not work well. This study will test whether virtual walking from different visual perspectives can reduce chronic neuropathic pain and improve quality of life after spinal cord injury. We will also compare which perspective works best. To better understand how the training works, we will use two tests-quantitative sensory testing (QST) and contact heat-evoked potentials (CHEPs)-to measure changes in the pain and nerve systems.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
19mo left

Started Jan 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Jan 2026Nov 2027

First Submitted

Initial submission to the registry

September 3, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 10, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

January 20, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2027

Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

1.9 years

First QC Date

September 3, 2025

Last Update Submit

January 19, 2026

Conditions

Keywords

neuropathic painvirtual walkingvirtual realityspinal cord injury painspinal cord injury

Outcome Measures

Primary Outcomes (1)

  • Proportion of participants with a clinically meaningful reduction in average pain intensity

    The primary outcome is the percentage of participants achieving a reduction of ≥1 point on the Numeric Rating Scale (NRS; 0 = no pain, 10 = worst imaginable pain) for average pain intensity. Pain intensity is assessed daily using a pain diary over one week, measured at 4 weeks and 12 weeks after the end of treatment, compared to baseline (1 week before treatment start).

    15 weeks

Secondary Outcomes (16)

  • Change in pain distribution

    Baseline (1 week before intervention) to 2, 3, 4, 7, and 15 weeks after start of intervention

  • Change in pain distribution

    Baseline (1 week before intervention) to 2, 3, 4, 7, and 15 weeks after start of intervention

  • Pain interference, diagnosis, type, and duration

    Baseline, 4 and 12 weeks post-treatment

  • Neuropathic pain quality

    Baseline, 4 and 12 weeks post-treatment

  • Severity of chronic pain

    Baseline, 4 and 12 weeks post-treatment

  • +11 more secondary outcomes

Study Arms (3)

Group 1

EXPERIMENTAL

Participants will receive virtual walking (VW) therapy with a personalized avatar. Using a green screen setup, a live video of the participant's upper body is combined with pre-recorded walking legs to create a full-body walking illusion, displayed on a large projection screen in a forest environment. The participant will be seated in a modified wheelchair that tilts 2° to each side to simulate pelvic movement during walking.

Behavioral: Virtual Walking

Group 2

SHAM COMPARATOR

Participants will receive virtual walking (VW) therapy without an avatar. The screen will display only a moving forest environment, and the wheelchair tilt will be omitted. This condition serves as a sham intervention, matching Group 1 in session number, duration, and procedure, but without the visual and vestibular walking components.

Behavioral: Sham Virtual Walking

Control Group

NO INTERVENTION

Participants will receive standard medical pain management only. They will not take part in virtual walking therapy but will complete the pain diary and questionnaires at the scheduled assessment time points.

Interventions

Virtual WalkingBEHAVIORAL

This virtual walking therapy uses a life-sized video avatar of the participant walking through a forest environment. A green screen setup combines a live video of the participant's upper body with pre-recorded walking legs, creating a full-body walking illusion. The participant is seated in a modified wheelchair that tilts 2° to each side to mimic pelvic movement during walking. This approach differs from the sham condition (Group 2), which displays only the moving forest without an avatar or wheelchair tilt, and from the standard care group (Group 3), which receives no virtual walking therapy.

Group 1

Participants view a moving forest environment on a large projection screen for 10 sessions over 2 weeks (each up to 20 minutes). No avatar of the participant is displayed, and the wheelchair tilt function is disabled. This differs from the experimental intervention (Group 1), which includes a life-sized walking avatar and wheelchair tilt to mimic pelvic movement, and from the standard care group (Group 3), which receives no virtual walking therapy.

Group 2

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Sufficient knowledge of German language to understand the instructions, assessments and to fill in questionnaires.
  • Age ≥ 18y, ≤ 75y
  • Chronic traumatic or non-traumatic SCI (\>6 month after SCI) with an SCI severity grade AIS A, B, C or D
  • At or below level spinal cord injury neuropathic pain on trunk or lower extremities diagnosed by a neurologist following the ISCIP classification (Bryce et al., 2012) of at least 4/10 intensity on a NRS (Langford et al., 2023)
  • Ability to draw with a pen

You may not qualify if:

  • \- Serious psychiatric disorders, which are accompanied by imminent or current acute harm to oneself or others, or which require inpatient psychiatric treatment for other reasons, or other indications of a foreseeable, seriously harmful effect of participation in the study based on the clinical impression from the psychological screening interview
  • Participants with a walking ability more than 5 minutes without walking aids
  • Pregnancy (anamnestic) in women of child-bearing age (18-49 years)
  • Known epilepsy
  • neurological disorders (multiple sclerosis, ALS, Guillan-Barré Syndrome, congenital disorders, polyneuropathy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Schweizer Paraplegiker Zentrum Nottwil

Nottwil, Canton of Lucerne, 6207, Switzerland

RECRUITING

Related Publications (31)

  • Mahnig S, Landmann G, Stockinger L, Opsommer E. Pain assessment according to the International Spinal Cord Injury Pain classification in patients with spinal cord injury referred to a multidisciplinary pain center. Spinal Cord. 2016 Oct;54(10):809-815. doi: 10.1038/sc.2015.219. Epub 2016 Jan 12.

    PMID: 26754471BACKGROUND
  • Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpaa M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015 Feb;14(2):162-73. doi: 10.1016/S1474-4422(14)70251-0. Epub 2015 Jan 7.

    PMID: 25575710BACKGROUND
  • Finnerup NB. Pain in patients with spinal cord injury. Pain. 2013 Dec;154 Suppl 1:S71-S76. doi: 10.1016/j.pain.2012.12.007. Epub 2012 Dec 22.

    PMID: 23375163BACKGROUND
  • Wydenkeller S, Maurizio S, Dietz V, Halder P. Neuropathic pain in spinal cord injury: significance of clinical and electrophysiological measures. Eur J Neurosci. 2009 Jul;30(1):91-9. doi: 10.1111/j.1460-9568.2009.06801.x. Epub 2009 Jun 25.

  • Wrigley PJ, Press SR, Gustin SM, Macefield VG, Gandevia SC, Cousins MJ, Middleton JW, Henderson LA, Siddall PJ. Neuropathic pain and primary somatosensory cortex reorganization following spinal cord injury. Pain. 2009 Jan;141(1-2):52-9. doi: 10.1016/j.pain.2008.10.007. Epub 2008 Nov 21.

  • Widerstrom-Noga E, Biering-Sorensen F, Bryce TN, Cardenas DD, Finnerup NB, Jensen MP, Richards JS, Rosner J, Taylor J. The international spinal cord injury pain basic data set (version 3.0). Spinal Cord. 2023 Oct;61(10):536-540. doi: 10.1038/s41393-023-00919-w. Epub 2023 Jul 25.

  • Von Korff M, Ormel J, Keefe FJ, Dworkin SF. Grading the severity of chronic pain. Pain. 1992 Aug;50(2):133-149. doi: 10.1016/0304-3959(92)90154-4.

  • Turk DC, Dworkin RH, Allen RR, Bellamy N, Brandenburg N, Carr DB, Cleeland C, Dionne R, Farrar JT, Galer BS, Hewitt DJ, Jadad AR, Katz NP, Kramer LD, Manning DC, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robinson JP, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Witter J. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain. 2003 Dec;106(3):337-345. doi: 10.1016/j.pain.2003.08.001.

  • Trost Z, Anam M, Seward J, Shum C, Rumble D, Sturgeon J, Mark V, Chen Y, Mitchell L, Cowan R, Perera R, Richardson E, Richards S, Gustin S. Immersive interactive virtual walking reduces neuropathic pain in spinal cord injury: findings from a preliminary investigation of feasibility and clinical efficacy. Pain. 2022 Feb 1;163(2):350-361. doi: 10.1097/j.pain.0000000000002348.

  • Sommer C, Richter H, Rogausch JP, Frettloh J, Lungenhausen M, Maier C. A modified score to identify and discriminate neuropathic pain: a study on the German version of the Neuropathic Pain Symptom Inventory (NPSI). BMC Neurol. 2011 Aug 23;11:104. doi: 10.1186/1471-2377-11-104.

  • Richardson EJ, McKinley EC, Rahman AKMF, Klebine P, Redden DT, Richards JS. Effects of virtual walking on spinal cord injury-related neuropathic pain: A randomized, controlled trial. Rehabil Psychol. 2019 Feb;64(1):13-24. doi: 10.1037/rep0000246. Epub 2018 Nov 8.

  • Pfau DB, Krumova EK, Treede RD, Baron R, Toelle T, Birklein F, Eich W, Geber C, Gerhardt A, Weiss T, Magerl W, Maier C. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): reference data for the trunk and application in patients with chronic postherpetic neuralgia. Pain. 2014 May;155(5):1002-1015. doi: 10.1016/j.pain.2014.02.004. Epub 2014 Feb 10.

  • Ozkul C, Kilinc M, Yildirim SA, Topcuoglu EY, Akyuz M. Effects of visual illusion and transcutaneous electrical nerve stimulation on neuropathic pain in patients with spinal cord injury: A randomised controlled cross-over trial. J Back Musculoskelet Rehabil. 2015;28(4):709-19. doi: 10.3233/BMR-140573.

  • Opsommer E, Korogod N, Stockinger L, Landmann G. Multimodal sensory evaluation of neuropathic spinal cord injury pain: an experimental study. Spinal Cord. 2021 Aug;59(8):842-854. doi: 10.1038/s41393-020-00607-z. Epub 2021 Jan 14.

  • Moseley LG. Using visual illusion to reduce at-level neuropathic pain in paraplegia. Pain. 2007 Aug;130(3):294-298. doi: 10.1016/j.pain.2007.01.007. Epub 2007 Mar 1.

  • Magerl W, Krumova EK, Baron R, Tolle T, Treede RD, Maier C. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain. 2010 Dec;151(3):598-605. doi: 10.1016/j.pain.2010.07.026. Epub 2010 Oct 20.

  • Maercker, A. L., R. (2001). Persönliche Reifung (Personal Growth) durch Belastungen und Traumata. Diagnostica, VOL.47,NO.3. https://doi.org/https://doi.org/10.1026//0012-1924.47.3.153

    RESULT
  • Langford DJ, Baron R, Edwards RR, Gewandter JS, Gilron I, Griffin R, Kamerman PR, Katz NP, McDermott MP, Rice ASC, Turk DC, Vollert J, Dworkin RH. What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update. Pain. 2023 Sep 1;164(9):1927-1930. doi: 10.1097/j.pain.0000000000002930. Epub 2023 Jun 7. No abstract available.

  • Kumru H, Soler D, Vidal J, Navarro X, Tormos JM, Pascual-Leone A, Valls-Sole J. The effects of transcranial direct current stimulation with visual illusion in neuropathic pain due to spinal cord injury: an evoked potentials and quantitative thermal testing study. Eur J Pain. 2013 Jan;17(1):55-66. doi: 10.1002/j.1532-2149.2012.00167.x. Epub 2012 May 18.

  • Kirshblum SC, Burns SP, Biering-Sorensen F, Donovan W, Graves DE, Jha A, Johansen M, Jones L, Krassioukov A, Mulcahey MJ, Schmidt-Read M, Waring W. International standards for neurological classification of spinal cord injury (revised 2011). J Spinal Cord Med. 2011 Nov;34(6):535-46. doi: 10.1179/204577211X13207446293695. No abstract available.

  • Kazis LE, Miller DR, Skinner KM, Lee A, Ren XS, Clark JA, Rogers WH, Spiro A 3rd, Selim A, Linzer M, Payne SM, Mansell D, Fincke RG. Patient-reported measures of health: The Veterans Health Study. J Ambul Care Manage. 2004 Jan-Mar;27(1):70-83. doi: 10.1097/00004479-200401000-00012.

  • Gustin SM, Bolding M, Willoughby W, Anam M, Shum C, Rumble D, Mark VW, Mitchell L, Cowan RE, Richardson E, Richards S, Trost Z. Cortical Mechanisms Underlying Immersive Interactive Virtual Walking Treatment for Amelioration of Neuropathic Pain after Spinal Cord Injury: Findings from a Preliminary Investigation of Thalamic Inhibitory Function. J Clin Med. 2023 Sep 4;12(17):5743. doi: 10.3390/jcm12175743.

  • de Araujo AVL, Neiva JFO, Monteiro CBM, Magalhaes FH. Efficacy of Virtual Reality Rehabilitation after Spinal Cord Injury: A Systematic Review. Biomed Res Int. 2019 Nov 13;2019:7106951. doi: 10.1155/2019/7106951. eCollection 2019.

  • Christen D, Killikelly C, Maercker A, Augsburger M. Item Response Model Validation of the German ICD-11 International Trauma Questionnaire for PTSD and CPTSD. Clin Psychol Eur. 2021 Dec 23;3(4):e5501. doi: 10.32872/cpe.5501. eCollection 2021 Dec.

  • Charlifue S, Post MW, Biering-Sorensen F, Catz A, Dijkers M, Geyh S, Horsewell J, Noonan V, Noreau L, Tate D, Sinnott KA. International Spinal Cord Injury Quality of Life Basic Data Set. Spinal Cord. 2012 Sep;50(9):672-5. doi: 10.1038/sc.2012.27. Epub 2012 Mar 27.

  • Braunwalder C, Muller R, Kunz S, Tough H, Landmann G, Fekete C. Psychosocial resources and chronic pain in individuals with spinal cord injury: evidence from the second Swiss national community survey. Spinal Cord. 2021 Apr;59(4):410-418. doi: 10.1038/s41393-020-00577-2. Epub 2020 Nov 19.

  • Braunwalder C, Ehrmann C, Hodel J, Muller R, von Matt D, Fekete C. Pain Trajectories During Initial Rehabilitation After Spinal Cord Injury: Do Psychosocial Resources and Mental Health Predict Trajectories? Arch Phys Med Rehabil. 2022 Jul;103(7):1294-1302. doi: 10.1016/j.apmr.2022.01.149. Epub 2022 Feb 11.

  • Bouhassira D, Branders S, Attal N, Fernandes AM, Demolle D, Barbour J, Ciampi de Andrade D, Pereira A. Stratification of patients based on the Neuropathic Pain Symptom Inventory: development and validation of a new algorithm. Pain. 2021 Apr 1;162(4):1038-1046. doi: 10.1097/j.pain.0000000000002130.

  • Biering-Sorensen F, Charlifue S, Chen Y, New PW, Noonan V, Post MWM, Rupp R, Vogel L. International Spinal Cord Injury Core Data Set (version 3.0)-including standardization of reporting. Spinal Cord. 2023 Jan;61(1):65-68. doi: 10.1038/s41393-022-00862-2. Epub 2022 Oct 28.

  • Schmerz.) Behr, M. B., M. . (2004). Skalen zum Erleben von Emotionen (SEE). Göttingen: Hogrefe.

    RESULT
  • Aerni, M. (2020). Machbarkeitsstudie: Virtual walking bei Personen mit neuropathischen Schmerzen infolge Querschnittlähmung. . Master thesis, University of applied sciences Zurich.

    RESULT

MeSH Terms

Conditions

Spinal Cord InjuriesNeuralgia

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesPeripheral Nervous System DiseasesNeuromuscular DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Gunther Landmann, KD Dr. med.

    Schweizer Paraplegiker Zentrum Nottwil

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gunther Landmann, KD Dr. med.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2025

First Posted

September 10, 2025

Study Start

January 20, 2026

Primary Completion (Estimated)

November 30, 2027

Study Completion (Estimated)

November 30, 2027

Last Updated

January 21, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the informed consent and ethics approval do not include permission for data sharing, and to ensure protection of participant privacy.

Locations